Company Filing History:
Years Active: 2024
Title: Innovations by Søren Rasmussen in Pain Modulation
Introduction
Søren Rasmussen is an accomplished inventor based in Espergærde, Denmark. He has made significant contributions to the field of pain modulation through his innovative work on oligonucleotides. His research focuses on the modulation of SCN9A expression, which plays a crucial role in pain perception.
Latest Patents
Rasmussen holds a patent for "Oligonucleotides for modulating SCN9A expression." This invention relates to oligonucleotides that are complementary to voltage-gated sodium ion channel encoding nucleic acids, specifically SCN9A, which encodes the voltage-gated sodium channel Na1.7. The oligonucleotides developed by Rasmussen are capable of inhibiting the expression of these channels, making them useful in the prevention or treatment of pain.
Career Highlights
Søren Rasmussen is associated with Hoffmann-La Roche Inc., where he continues to advance his research in the field of pain modulation. His work has the potential to lead to new therapeutic approaches for individuals suffering from chronic pain conditions.
Collaborations
Rasmussen collaborates with notable colleagues, including Lykke Pedersen and Gianluigi Lichinchi. Their combined expertise contributes to the innovative research being conducted at Hoffmann-La Roche Inc.
Conclusion
Søren Rasmussen's contributions to the field of pain modulation through his patent on oligonucleotides represent a significant advancement in medical research. His work has the potential to improve the quality of life for many individuals suffering from pain.